Translations:Dipeptidyl peptidase-4 inhibitor/17/en: Difference between revisions

From Azupedia
Jump to navigation Jump to search
VisualWikitext
FuzzyBot (talk | contribs)
14,944 edits
Importing a new version from external source
 
(No difference)

Latest revision as of 17:34, 12 March 2024

Information about message (contribute)
This message has no documentation. If you know where or how this message is used, you can help other translators by adding documentation to this message.
Message definition (Dipeptidyl peptidase-4 inhibitor)
==Combination drugs==
Some DPP-4 inhibitor drugs have received approval from the FDA to be used with [[metformin]] concomitantly with additive effect to increase the level of glucagon-like peptide 1 (GLP-1) which also decreases [[hepatic]] [[gluconeogenesis|glucose production]].

Combination drugs

Some DPP-4 inhibitor drugs have received approval from the FDA to be used with metformin concomitantly with additive effect to increase the level of glucagon-like peptide 1 (GLP-1) which also decreases hepatic glucose production.

Retrieved from "https://wiki.tiffa.net/w/index.php?title=Translations:Dipeptidyl_peptidase-4_inhibitor/17/en&oldid=128230"